Sinoway Industrial Co., Ltd.

Pitavastatin Calcium 147526-32-7 Pitavastatin Calcium 147526-32-7

Pitavastatin Calcium 147526-32-7
Verwandte Produkte
  • L-Glutathion reduziert (GSH) 70-18-8

    L-Glutathion ReducedBasic Informationen von L-Glutathion Reduced: Produktname: L-Glutathion ReducedMolecular Formel: C20H32N6O12S2Molecular Gewicht: 612.63CAS No.:70-18-8ENIECE No: 200-725-4Appearanc ...

  • Kupferpeptid (GHK) 2-CU 49557-75-7

    Kupferpeptid GHK-CuBasische Information des Kupferpeptids GHK-Cu: Produktname (GHK) 2-Cu (Kupferpeptid) SynonymeGHK-Cu (Kupferpeptid) CAS # 49557-75-7MolekularformelC28H46N12O8Cu Molekulargewicht742,2 ...

  • Isoflavone in Soja 574-12-9

    Sojabohnenextrakt1.Basisinformationen von Sojabohnenextrakt: Produktname: SojabohnenextraktQuelle: Glycin maxUsed Teil: Keim / Bohne PulpSpec .: Gesamtsoja Isoflavon 40%, 80% durch HPLCNameSoybean Extract PowderTyp ...

Grundlegende Informationen zu Pitavastatin Calcium 147526-32-7

Name

Pitavastatincalcium

CAS:

147526-32-7

Molecular Formula

C50H46CaF2N2O8

Molecular Weight

880.98

Quality Standard

In-house Standard, Assay: >99.0%

Package Size

For small quantity: Double plastic bag inside, Aluminum foil bag outside

For commercial quantity: 25kg fiber drum & Aluminum tin

Brief Introduction

Pitavastatin (usually as a calcium salt) is a member of the blood cholesterol lowering medication 
class of statins, marketed in the United States under the trade name Livalo. Like other statins, it
is an inhibitor of HMG-CoA reductase, the enzyme that catalyses the first step of cholesterol synthesis.

It has been available in Japan since 2003, and is being marketed in South Korea and in India.
[2] It is expected that pitavastatin will be approved outside Southeast Asia as well.
[3] In the US, it received FDA approval in 2009. Kowa Pharmaceuticals is the owner of the American patent to pitavastatin.


Verwendung von Pitavastatin Calcium 147526-32-7

  • Pitavastatin Calcium ist angezeigt für Hypercholesterinämie (erhöhtes Cholesterin) und zur Vorbeugung von Herz-Kreislauf-Erkrankungen.

COA von Pitavastatin Calcium 147526-32-7

Pitavastatin Calcium 147526-32-7

MORE_DETAIL Pitavastatin Calcium 147526-32-7

Grundlegende Informationen zu Pitavastatin Calcium 147526-32-7

Name

Pitavastatincalcium

CAS:

147526-32-7

Molecular Formula

C50H46CaF2N2O8

Molecular Weight

880.98

Quality Standard

In-house Standard, Assay: >99.0%

Package Size

For small quantity: Double plastic bag inside, Aluminum foil bag outside

For commercial quantity: 25kg fiber drum & Aluminum tin

Brief Introduction

Pitavastatin (usually as a calcium salt) is a member of the blood cholesterol lowering medication 
class of statins, marketed in the United States under the trade name Livalo. Like other statins, it
is an inhibitor of HMG-CoA reductase, the enzyme that catalyses the first step of cholesterol synthesis.

It has been available in Japan since 2003, and is being marketed in South Korea and in India.
[2] It is expected that pitavastatin will be approved outside Southeast Asia as well.
[3] In the US, it received FDA approval in 2009. Kowa Pharmaceuticals is the owner of the American patent to pitavastatin.


Verwendung von Pitavastatin Calcium 147526-32-7

  • Pitavastatin Calcium ist angezeigt für Hypercholesterinämie (erhöhtes Cholesterin) und zur Vorbeugung von Herz-Kreislauf-Erkrankungen.

COA von Pitavastatin Calcium 147526-32-7

Pitavastatin Calcium 147526-32-7
Verwandte Artikel
Hinterlasse eine Nachricht Email uns

Wir werden uns innerhalb von 24 Stunden bei Ihnen melden.

  • TEL:+ 86-0592-5854962
  • FAX:+ 86-0592-5854960
  • EMAIL: xie@china-sinoway.com
  • ADDRESS:Etage 16, Huicheng Business Center, Nr. 839, Xiahe Rd., Siming Dist. Xiamen, Fujian, China
//